Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European prospective investigation into cancer and nutrition

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 10, 2011, Pages 2174-2182

  Rohrmann, Sabine ^a,b   Linseisen, Jakob ^a,c   Becker, Susen ^a   Allen, Naomi ^d   Schlehofer, Brigitte ^a   Overvad, Kim ^f   Olsen, Anja ^g   Tjønneland, Anne ^g   Melin, Beatrice S ^h   Lund, Eiliv ⁱ   Vineis, Paolo ^j,k   Grioni, Sara ^l   Tumino, Rosario ^m   Palli, Domenico ⁿ   Mattiello, Amalia ^o   Bonet, Catalina ^p   Chirlaque, Maria Dolores ^q,r   Sánchez, María José ^r,s   Rodríguez, Laudina ^t   Dorronsoro, Miren ^r,u   Ardanaz, Eva ^r,v   Lagiou, Pagona ^w,z   Trichopoulou, Antonia ^w,x   Trichopoulos, Dimitrios ^y,z   Dossus, Laure ^a   Grote, Verena A ^a   Boeing, Heiner ^aa   Aleksandrova, Krasimira ^aa   Bas Bueno de Mesquita, H ^ab,ac   Van Duijnhoven, Fränzel J B ^ab   Peeters, Petra H M ^ac   Khaw, Kay Tee ^ad   Wareham, Nicholas J ^ae   Key, Timothy J ^e   Rinaldi, Sabina ^af   Romieux, Isabelle ^af   Gallo, Valentina ^j   Michaud, Dominique S ^j   Riboli, Elio ^j   Kaaks, Rudolf ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^h UMEÅ UNIVERSITY   (Sweden)

ⁱ UNIVERSITY OF TROMSØ   (Norway)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k HuGeF Foundation   (Italy)

^l NATIONAL CANCER INSTITUTE   (Italy)

^m CIVILE M P AREZZO HOSPITAL   (Italy)

ⁿ CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^q Murcia Regional Health Authority   (Spain)

^r CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^s ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^t Health and Health Care Services Council   (Spain)

^u Public Health Department of Gipuzkoa   (Spain)

^v INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^w UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^x HELLENIC HEALTH FOUNDATION   (Greece)

^y BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^z HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^aa GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^ab NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ac UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ad UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ae MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^af INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; NEUROMA, ACOUSTIC; NUTRITIONAL STATUS; PROGNOSIS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 80053503301     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0179     Document Type: Article

References (30)

1. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008;113:1953-68.
2. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000;21:215-44. (Pubitemid 32275588)
3. Joseph D'Ercole A, Ye P. Expanding the mind: insulin-like growth factor I and brain development. Endocrinology 2008;149:5958-62.
4. Zumkeller W, Westphal M. The IGF/IGFBP system in CNS malignancy. Mol Pathol 2001;54:227-9. (Pubitemid 32730397)
5. Russo VC, Gluckman PD, Feldman EL, Werther GA. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 2005;26:916-43. (Pubitemid 41770158)
6. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004;4:505-18. (Pubitemid 38868620)
7. Pan W, Kastin AJ. Interactions of IGF-1 with the blood-brain barrier in vivo and in situ. Neuroendocrinology 2000;72:171-8.
8. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
9. Gunnell D, Oliver SE, Donovan JL, Peters TJ, Gillatt D, Persad R, et al. Do height-related variations in insulin-like growth factors underlie the associations of stature with adult chronic disease?J Clin Endocrinol Metab 2004;89:213-8. (Pubitemid 38183884)
10. Moore SC, Rajaraman P, Dubrow R, Darefsky AS, Koebnick C, Hollenbeck A, et al. Height, body mass index, and physical activity in relation to glioma risk. Cancer Res 2009;69:8349-55.
11. Crowe FL, Key TJ, Allen NE, Appleby PN, Overvad K, Grønbæk H, et al. A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Hum Biol 2011;38:194-202.
12. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, et al. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 2002;13:395-400. (Pubitemid 34666594)
13. Lönn S, Inskip PD, Pollak MN, Weinstein SJ, Virtamo J, Albanes D, et al. Glioma risk in relation to serum levels of insulin-like growth factors. Cancer Epidemiol Biomarkers Prev 2007;16:844-6. (Pubitemid 46650593)
14. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53. (Pubitemid 38529873)
15. Glick RP, Lichtor T, Unterman TG. Insulin-like growth factors in central nervous system tumors. J Neurooncol 1997;35:315-25. (Pubitemid 27511134)
16. Riboli E, Kaaks R. The EPIC project: rationale and study design. European prospective investigation into cancer and nutrition. Int J Epidemiol 1997;26 Suppl 1:S6-14.
17. Kaaks R, Slimani N, Riboli E. Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European prospective investigation into cancer and nutrition. Int J Epidemiol 1997;26 Suppl 1:S26-36. (Pubitemid 27129687)
18. Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, Boeing H, et al. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European prospective investigation into cancer and nutrition (EPIC). Public Health Nutr 2002;5:1147-62. (Pubitemid 36313610)
19. Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, et al. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 2010;126:1702-15.
20. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, et al. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 2008;149:461-71, W83-8.
21. Galan P, Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010;11:530-42.
22. Daftary SS, Gore AC. IGF-1 in the brain as a regulator of reproductive neuroendocrine function. Exp Biol Med (Maywood) 2005;230:292-306. (Pubitemid 40627681)
23. Trojan J, Cloix JF, Ardourel MY, Chatel M, Anthony DD. Insulin-like growth factor type I biology and targeting in malignant gliomas. Neuroscience 2007;145:795-811. (Pubitemid 46441671)
24. Tranque PA, Calle R, Naftolin F, Robbins R. Involvement of protein kinase-C in the mitogenic effect of insulin-like growth factor-I on rat astrocytes. Endocrinology 1992;131:1948-54.
25. Åberg ND, Blomstrand F, Åberg MAI, Björklund U, Carlsson B, Carlsson-Skwirut C, et al. Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexion 43 expression in vitro. J Neuroscience Res 2003;74:12-22.
26. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997;272:12181-8. (Pubitemid 27202802)
27. Rajah R, LeeKW, Cohen P. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. Cell Growth Differ 2002;13:163-71. (Pubitemid 34507095)
28. Lönn S, Rothman N, Shapiro WR, Fine HA, Selker RG, Black PM, et al. Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol 2008;10:553-9.
29. Zumkeller W. IGFs and IGF-binding proteins as diagnostic markers and biological modulators in brain tumors. Expert Rev Mol Diagn 2002;2:473-7. (Pubitemid 35014421)
30. Propp JM, McCarthy BJ, Davis FG, Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neuro-oncol 2006;8:1-11. (Pubitemid 43158221)